Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Cresco Labs ( (TSE:CL) ) just unveiled an announcement.
Cresco Labs has opened Sunnyside Bridgeport, a new cannabis dispensary at 435 Main Street in Bridgeport, Ohio, marking its seventh location in the state and 73rd nationwide. Positioned near major transportation routes by the Ohio River, the store aims to expand access in the Ohio Valley and deepen the company’s presence in the strategically important Ohio market.
The dispensary offers a broad range of cannabis products from Cresco Labs’ leading brand portfolio, along with curated accessories, serving customers 21 and older via in-store shopping and online ordering with pickup. The move reinforces Cresco Labs’ education-first, customer-focused retail model under the Sunnyside brand and supports its broader effort to build national scale and consumer trust in regulated cannabis retail.
The opening of Sunnyside Bridgeport also complements Cresco Labs’ emphasis on normalizing and professionalizing cannabis through a traditional retail experience backed by community outreach initiatives. By growing its Ohio footprint, the company strengthens its operational footprint in a key region, which could enhance brand visibility and consumer loyalty as legal cannabis access continues to expand.
The most recent analyst rating on (TSE:CL) stock is a Hold with a C$1.00 price target. To see the full list of analyst forecasts on Cresco Labs stock, see the TSE:CL Stock Forecast page.
Spark’s Take on CL Stock
According to Spark, TipRanks’ AI Analyst, CL is a Neutral.
The score is held back primarily by weak financial performance (sharp revenue contraction, continued net losses, and worsening leverage despite positive cash flow). Technicals are mixed with soft momentum, while the earnings call adds modest support through margin/cash-flow progress and improved maturity profile but is tempered by near-term revenue and margin headwinds. Valuation is difficult to support due to negative earnings and no dividend yield.
To see Spark’s full report on CL stock, click here.
More about Cresco Labs
Cresco Labs Inc. is a U.S. cannabis company focused on cultivation, production and distribution of branded cannabis products, as well as operating retail dispensaries under the Sunnyside banner. Its portfolio includes brands such as Cresco, High Supply, FloraCal, Good News, Wonder Wellness Co., Mindy’s and Remedi, with a strategy centered on consumer packaged goods, education-focused retail, and community engagement across national markets.
Average Trading Volume: 121,375
Technical Sentiment Signal: Sell
Current Market Cap: C$574.5M
See more data about CL stock on TipRanks’ Stock Analysis page.